HIV-1 vaccine development: Pinning down a moving target

November 12, 2012

HIV-1 is a genetically diverse collection of viruses, making it a moving target in vaccine development.

In a study published in the , researchers led by Brad Jones at the University of Toronto in investigated the feasibility of eliminating HIV-infected cells by targeting cellular immune responses against a human endogenous retrovirus (HERV).

HERVs are the DNA remnants of ancient infectious retroviruses that became part of the germ line cells of our ancestors.

Jones and colleagues found that stimulated the expression of HERV proteins, effectively tagging HIV-infected cells.

targeted to these proteins specifically eliminated cells infected with several different strains of HIV in vitro. This study suggests that HERV-targeted immune responses should be considered in the development of HIV vaccines.

Explore further: Research illuminating long-term non-progression suggests novel vaccination strategy for HIV

More information: HERV-K-targeted T-cells eliminate diverse HIV-1/2 and SIV primary isolates, Journal of Clinical Investigation, 2012.

Related Stories

Recommended for you

Researchers find alternative pathways to HIV antibodies

May 4, 2016

The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...

Fireflies light the way to female HIV transmission

April 27, 2016

Finding the vulnerable points where HIV enters the female reproductive tract is like searching for needles in a haystack. But Northwestern Medicine scientists have solved that challenge by creating a glowing map of the very ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.